Biotechnology Stocks II: Returns for Nurix Therapeutics, Inc. (NRIX)
NRIX has no dividends.
Table and Chart of NRIX Performance
See what a $1,000 investment in NRIX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NRIX Returns | |
|---|---|
| Start Date | Aug-31-2020 |
| Start Price | $23.40 |
| End Date | Jan-16-2025 |
| End Price | $19.49 |
| # Prices | 54 |
| Min Date | Oct-31-2023 |
| Min Price | $5.59 |
| Max Date | Nov-30-2020 |
| Max Price | $42.62 |
| Total Return | -16.71% |
| Annualized Return | -3.98% |
| Current Value of $1,000 Purchase | $833 |
| Number Returns | 1,431 |
| Average Return | -9.30% |
| Number Profitable Returns | 429 |
| Percent Profitable Returns | 29.98% |
| Number Unprofitable Returns | 1,002 |
| Percent Unprofitable Returns | 70.02% |
| Profitable to Unprofitable Returns Ratio | 0.43 |
| NRIX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,380,600,000 |
| Beta | 2.200 | Price to Sales | 24.47 |
| Earnings per Share | $-2.9000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.788 |
| PRICE DATA | |
| 52 Week High | $29.56 |
| 52 Week Low | $7.65 |
| Analyst Target Price | $31.94 |
| 50-Day Moving Average | $21.75 |
| 200-Day Moving Average | $20.35 |
| FINANCIAL DATA | |
| Revenue per Share | $0.922 |
| Revenue | $56,424,000 |
| Profit Margin | 0% |
| Return on Equity | -58% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NRIX Compare Returns with S&P 500
NRIX Trendline Chart
NRIX Moving Average Chart
NRIX Stock Return Map - See Patterns of Gains and Losses
NRIX Stock Returns/Purchase Dates